Immediate Impact
69 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
2024 Standout
Works of Alessandro Germini being referenced
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
2013
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alessandro Germini | 154 | 243 | 54 | 113 | 21 | 360 | |
| U Plengvanit | 163 | 203 | 47 | 106 | 27 | 336 | |
| H Furukawa | 171 | 118 | 76 | 74 | 33 | 401 | |
| Settimio Zazza | 158 | 230 | 35 | 206 | 18 | 402 | |
| Pompilia Radu | 101 | 185 | 96 | 167 | 32 | 386 | |
| Y Ibuki | 75 | 247 | 74 | 135 | 24 | 358 | |
| Rafael Díaz-Nieto | 228 | 166 | 122 | 47 | 32 | 405 | |
| Cheng‐Chung Tsai | 168 | 175 | 89 | 102 | 15 | 314 | |
| M Dellepiane | 147 | 316 | 71 | 199 | 14 | 402 | |
| Ayşegül Özakyol | 73 | 116 | 30 | 113 | 24 | 314 | |
| Makoto Fujita | 142 | 259 | 75 | 111 | 21 | 364 |
All Works
Login with ORCID to disown or claim papers
Loading papers...